InvestorsHub Logo

Lemoncat

08/23/20 3:05 PM

#319910 RE: roiresearch #319902

Leo did not pursue covid but rather other institutions came to ipix looking into brilacidin. I think leo was a reluctant passenger until May when he forked over the 35k.



I think you're completely wrong.

Two weeks before the first COVID PR we had a PR talking about out-licensing negotiations for B-OM. Essentially we were going to send it it auction as we were out of options.

COVID provided an high profile opportunity to finally shine some light on the pipeline. It worked pretty well too. Our stock price soared 4x over a period where we sold over 50 million shares and raised our cash balance to $6M. If we did not have to raise money so aggressively our stock price likely would have soared well above $1.

COVID was a breath of life for an IPIX at the end of its rope. Leo masterfully took advantage of the hype and got this company back on solid footing. There was no reluctance on his part at any stage of COVID.


Leo also said he expects to hear back on grant in September based upon 2-3 month review time



When, where, and to whom did he say this?


Go IPIX!